Annual Short Term Debt
$1.14 M
-$1.37 M-54.63%
31 December 2023
Summary:
Protagonist Therapeutics annual short term debt is currently $1.14 million, with the most recent change of -$1.37 million (-54.63%) on 31 December 2023. During the last 3 years, it has fallen by -$1.06 million (-48.14%). PTGX annual short term debt is now -54.63% below its all-time high of $2.52 million, reached on 31 December 2022.PTGX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$45.00 K
+$45.00 K+100.00%
30 September 2024
Summary:
Protagonist Therapeutics quarterly short term debt is currently $45.00 thousand, with the most recent change of +$45.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has dropped by -$1.10 million (-96.06%). PTGX quarterly short term debt is now -98.27% below its all-time high of $2.60 million, reached on 31 March 2023.PTGX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -96.1% |
| 3 y3 years | -48.1% | -98.0% |
| 5 y5 years | -9.2% | -96.4% |
PTGX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.6% | at low | -98.3% | |
| 5 y | 5 years | -54.6% | at low | -98.3% | |
| alltime | all time | -54.6% | -98.3% |
Protagonist Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $45.00 K(>+9900.0%) |
| June 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $462.00 K(-59.5%) |
| Dec 2023 | $1.14 M(-54.6%) | $1.14 M(-36.7%) |
| Sept 2023 | - | $1.80 M(-26.3%) |
| June 2023 | - | $2.45 M(-5.9%) |
| Mar 2023 | - | $2.60 M(+3.3%) |
| Dec 2022 | $2.52 M(+14.3%) | $2.52 M(+3.4%) |
| Sept 2022 | - | $2.43 M(+3.4%) |
| June 2022 | - | $2.35 M(+3.4%) |
| Mar 2022 | - | $2.27 M(+3.4%) |
| Dec 2021 | $2.20 M | $2.20 M(+8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $2.03 M(+29.4%) |
| June 2021 | - | $1.57 M(+3.6%) |
| Mar 2021 | - | $1.51 M(+3.6%) |
| Dec 2020 | $1.46 M(+16.2%) | $1.46 M(+3.8%) |
| Sept 2020 | - | $1.41 M(+3.8%) |
| June 2020 | - | $1.35 M(+3.8%) |
| Mar 2020 | - | $1.31 M(+4.0%) |
| Dec 2019 | $1.26 M(>+9900.0%) | $1.26 M(+3.9%) |
| Sept 2019 | - | $1.21 M(+3.9%) |
| June 2019 | - | $1.16 M(+3.9%) |
| Mar 2019 | - | $1.12 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Protagonist Therapeutics annual short term debt?
- What is the all time high annual short term debt for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly short term debt year-on-year change?
What is Protagonist Therapeutics annual short term debt?
The current annual short term debt of PTGX is $1.14 M
What is the all time high annual short term debt for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual short term debt is $2.52 M
What is Protagonist Therapeutics quarterly short term debt?
The current quarterly short term debt of PTGX is $45.00 K
What is the all time high quarterly short term debt for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly short term debt is $2.60 M
What is Protagonist Therapeutics quarterly short term debt year-on-year change?
Over the past year, PTGX quarterly short term debt has changed by -$1.10 M (-96.06%)